Avacta Group (LON:AVCT) Shares Pass Above 200-Day Moving Average – Here’s What Happened

Avacta Group Plc (LON:AVCT)’s stock price crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 67.41 and traded as high as GBX 75. Avacta Group shares last traded at GBX 73.60, with a volume of 1,133,914 shares changing hands.

Avacta Group Price Performance

The stock has a market capitalization of £334.96 million, a price-to-earnings ratio of -7.62 and a beta of 1.12. The company has a debt-to-equity ratio of 602.46, a current ratio of 0.89 and a quick ratio of 4.96. The company has a 50-day simple moving average of GBX 76.19 and a two-hundred day simple moving average of GBX 67.41.

Avacta Group (LON:AVCT) last released its quarterly earnings results on Tuesday, May 19th. The biotechnology company reported GBX (9.27) earnings per share for the quarter. Avacta Group had a negative net margin of 33,961.06% and a negative return on equity of 2,929.47%. The business had revenue of GBX 11 million for the quarter. On average, equities research analysts predict that Avacta Group Plc will post -9.9011833 earnings per share for the current year.

About Avacta Group

Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics.
The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US.

Our proprietary pre|CISION® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).